|
[Related PubMed/MEDLINE]
Total Number of Papers: 1681
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: DA |
| Long Form |
: dopaminergic |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
123I-Iofluopane Single-Photon Emission Computed Tomography as an Imaging Biomarker of Pre-Synaptic Dopaminergic System after Moderate-to-Severe Traumatic Brain Injury. |
DAT, MP, SBR, SD, SPECT, TBI |
| 2 |
2020 |
Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging. |
FC, VTA |
| 3 |
2020 |
An In Vitro Partial Lesion Model of Differentiated Human Mesencephalic Neurons: Effect of Pericyte Secretome on Phenotypic Markers. |
LUHMES, PD, PDGF-BB |
| 4 |
2020 |
Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling. |
CREB, ER, PD, PLA2G6, UPR |
| 5 |
2020 |
Baicalin Represses C/EBPbeta via Its Antioxidative Effect in Parkinson's Disease. |
alpha-Syn, GO, LB, MPTP, PD, ROS, SN |
| 6 |
2020 |
Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. |
PD, SN |
| 7 |
2020 |
Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing Neurons. |
LPL, MCL, TGs |
| 8 |
2020 |
CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. |
CNTNAP4, CSF, ELISAs, PD, SN |
| 9 |
2020 |
Cocaine self-administration abolishes endocannabinoid-mediated long-term depression of glutamatergic synapses in the ventral tegmental area. |
eCB, LTD, VTA |
| 10 |
2020 |
Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats. |
DREADDs |
| 11 |
2020 |
Crocin Reverses Depression-Like Behavior in Parkinson Disease Mice via VTA-mPFC Pathway. |
FST, mPFC, MPTP, mTOR, PD, PDD, VTA |
| 12 |
2020 |
Curcumin-Activated Mesenchymal Stem Cells Derived from Human Umbilical Cord and Their Effects on MPTP-Mouse Model of Parkinson's Disease: A New Biological Therapy for Parkinson's Disease. |
CM-CUR, hUC-MSCs-CUR, MAP2, PD, TH |
| 13 |
2020 |
Differential Expression of microRNA Profiles and Wnt Signals in Stem Cell-Derived Exosomes During Dopaminergic Neuron Differentiation. |
EpiSCs, ESCs, miRNAs, TH |
| 14 |
2020 |
Direct Reprogramming of Human Fetal- and Stem Cell-Derived Glial Progenitor Cells into Midbrain Dopaminergic Neurons. |
hGPCs |
| 15 |
2020 |
Does altering proteasomal activity and trafficking reduce the arborization mediated specific vulnerability of SNpc dopaminergic neurons of Parkinson's disease? |
PD, SNpc, VTA |
| 16 |
2020 |
Dopaminergic modulation of olfactory-evoked motor output in sea lampreys (Petromyzon marinus L.). |
OB |
| 17 |
2020 |
Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders. |
APO, CLO, GH, NA, PRL |
| 18 |
2020 |
Dose-dependent effects of estrogen on prediction error related neural activity in the nucleus accumbens of healthy young women. |
NAc, PE |
| 19 |
2020 |
Downregulation of eEF1A/EFT3-4 Enhances Dopaminergic Neurodegeneration After 6-OHDA Exposure in C. elegans Model. |
6-OHDA, mTOR, PD, PI3K, RNAi |
| 20 |
2020 |
Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a beta-arrestin2-biased mechanism. |
DRD2, IL-1beta, MPTP, PD |
| 21 |
2020 |
Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1beta signaling pathway in MPTP-induced Parkinson's disease model. |
CASP, ECH, IL-1beta, MPTP, NLRP3, PD, SN, TH |
| 22 |
2020 |
Effect of Wenshen-Yanggan Decoction on Movement Disorder and Substantia Nigra Dopaminergic Neurons in Mice with Chronic Parkinson's Disease. |
Bcl-2, ELISA, p-JNK, PD, TH |
| 23 |
2020 |
Effects of brief inhibition of the ventral tegmental area dopamine neurons on the cocaine seeking during abstinence. |
CS, TH, VTA |
| 24 |
2020 |
Effects on Dopaminergic Neurons Are Secondary in COX-Deficient Locomotor Dysfunction in Drosophila. |
COX |
| 25 |
2020 |
Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction. |
DOPAL, PD |
| 26 |
2020 |
Emergence of novel functions in striatal low-threshold spike interneurons (Commentary on Gazan et al., 2019). |
GLU, SPNs, top |
| 27 |
2020 |
Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N. |
iPSC, PD, VPS35 |
| 28 |
2020 |
Enhanced Hyaluronan Signaling and Autophagy Dysfunction by VPS35 D620N. |
ECM, HA, HMMR, PD, RNA-Seq |
| 29 |
2020 |
Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease. |
AD, FGF21, PD, SN |
| 30 |
2020 |
Functional dopaminergic neurons derived from human chorionic mesenchymal stem cells ameliorate striatal atrophy and improve behavioral deficits in Parkinsonian rat model. |
HCMSCs, PD |
| 31 |
2020 |
Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra. |
AAVs, GFAP, GLT-1, PD, PSD-95, shRNA, siRNAs, SNpc |
| 32 |
2020 |
Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN(p. C253Y). |
iPSC, PD |
| 33 |
2020 |
Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice. |
Grx1, PD, SNpc |
| 34 |
2020 |
Heterogeneous expression of dopaminergic markers and Vglut2 in mouse mesodiencephalic dopaminergic nuclei A8-A13. |
DAT, TH, VGLUT2 |
| 35 |
2020 |
Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria. |
ACM, PD |
| 36 |
2020 |
Identification of a molecular basis for the juvenile sleep state. |
--- |
| 37 |
2020 |
In silico Hierarchical Clustering of Neuronal Populations in the Rat Ventral Tegmental Area Based on Extracellular Electrophysiological Properties. |
AP, CV, VTA |
| 38 |
2020 |
In Vivo Assessment of Cell Death and Nigrostriatal Pathway Integrity Following Continuous Expression of C3 Transferase. |
AAV, EYFP, PD, SNc, TH |
| 39 |
2020 |
Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of alpha-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling. |
IR, PD, PGC, PLK2, ROS, SNCA |
| 40 |
2020 |
Investigating the influence of perinatal nicotine and alcohol exposure on the genetic profiles of dopaminergic neurons in the VTA using miRNA-mRNA analysis. |
VTA |
| 41 |
2020 |
Involvement of MEK5/ERK5 signaling pathway in manganese-induced cell injury in dopaminergic MN9D cells. |
ERK5, IPD, MEK5, Mn, ROS |
| 42 |
2020 |
Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinsons Disease. |
CREB, GCM-LGF, LGF, MAPKs, SN, TNF-alpha |
| 43 |
2020 |
Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease. |
CREB, FMRP, FXS, ILBD, MMP9, PD, PKC, SNc |
| 44 |
2020 |
Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. |
EOPD, PD |
| 45 |
2020 |
MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling. |
Eya, GDNF, Six2 |
| 46 |
2020 |
Metabolic alterations in Parkinson's disease astrocytes. |
PD |
| 47 |
2020 |
Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells. |
hPSCs, PD, scRNA-seq |
| 48 |
2020 |
miR-7 Controls the Dopaminergic/Oligodendroglial Fate through Wnt/beta-catenin Signaling Regulation. |
--- |
| 49 |
2020 |
Mitochondrial Homeostasis and Signaling in Parkinson's Disease. |
PD |
| 50 |
2020 |
Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model. |
DAT, GFAP, Iba-1, MPTP, NEIL1, PD, TH |
| 51 |
2020 |
Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence. |
nAChRs |
| 52 |
2020 |
Neurochemical and neuroinflammatory perturbations in two Gulf War Illness models: Modulation by the immunotherapeutic LNFPIII. |
CORT, DEET, DFP, GW, GWI, LNFPIII, PB, PM |
| 53 |
2020 |
Neuronal activity triggers uptake of hematopoietic extracellular vesicles in vivo. |
EVs |
| 54 |
2020 |
NF-kappaB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols. |
NF-kappaB, PD |
| 55 |
2020 |
NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin. |
IL-1 beta, NLRP3, PD |
| 56 |
2020 |
Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. |
--- |
| 57 |
2020 |
Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase. |
CNS, PD, PGK, ROS |
| 58 |
2020 |
Olfactory ensheathing cells improve the survival of porcine neural xenografts in a Parkinsonian rat model. |
hfVM, OECs, PD, pfVM |
| 59 |
2020 |
Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts. |
PD |
| 60 |
2020 |
Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review. |
PD, SNpc, TCM |
| 61 |
2020 |
Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells. |
HDs, iPSCs, NTFs, PD, SN, TDNs |
| 62 |
2020 |
Pathogenic insights to Parkin-linked model mice. |
PD |
| 63 |
2020 |
Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons. |
PD, SAPNS |
| 64 |
2020 |
PERK-Mediated eIF2alpha Phosphorylation Contributes to The Protection of Dopaminergic Neurons from Chronic Heat Stress in Drosophila. |
ER, PD, UPR |
| 65 |
2020 |
PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila. |
PD |
| 66 |
2020 |
Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease. |
MPTP, MWM, PD, SNpc |
| 67 |
2020 |
Polyphenols from Toona sinensiss Seeds Alleviate Neuroinflammation Induced by 6-Hydroxydopamine Through Suppressing p38 MAPK Signaling Pathway in a Rat Model of Parkinson's Disease. |
CCK-8, COX-2, iNOS, PTSS, SD, TNF-alpha |
| 68 |
2020 |
Postnatal functional inactivation of the ventral subiculum enhances dopaminergic responses in the core part of the nucleus accumbens following ketamine injection in adult rats. |
NAcc, PND8, SUB, TTX |
| 69 |
2020 |
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease. |
DAPs, iPSC, PD |
| 70 |
2020 |
Preclinical evaluation of patient-derived cells shows promise for Parkinson's disease. |
iPSCs, PD |
| 71 |
2020 |
Prenatal Ethanol Exposure and Postnatal Environmental Intervention Alter Dopaminergic Neuron and Microglia Morphology in the Ventral Tegmental Area During Adulthood. |
PE, VTA |
| 72 |
2020 |
Pro-survival and anti-inflammatory roles of NF-kappaB c-Rel in the Parkinson's disease models. |
NF-kappaB, PD, SNpc |
| 73 |
2020 |
Protective Effect of Fucoidan against MPP+-Induced SH-SY5Y Cells Apoptosis by Affecting the PI3K/Akt Pathway. |
PD |
| 74 |
2020 |
Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways. |
APO, HSYA, IHC, PD, SN, STR, TH |
| 75 |
2020 |
Protective effect of metformin against rotenone-induced parkinsonism in mice. |
ER, PD, SN |
| 76 |
2020 |
Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. |
HFD, LPS, ROT |
| 77 |
2020 |
Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons. |
AAV, PD, VM |
| 78 |
2020 |
Reduced Dpp expression accelerates inflammation-mediated neurodegeneration through activated glial cells during altered innate immune response in Drosophila. |
Dpp, PD, PQ, TGF-beta, WT |
| 79 |
2020 |
Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D-ND6 pathway in the MPTP/MPP+ -induced model of Parkinson's disease. |
MEF2D, MPTP, ND6, PD, Sal |
| 80 |
2020 |
The onjisaponin B metabolite tenuifolin ameliorates dopaminergic neurodegeneration in a mouse model of Parkinson's disease. |
IL-1beta, IL-6, MPTP, OB, PD |
| 81 |
2020 |
The Potential Role of Astrocytes in Parkinson's Disease (PD). |
ALS, AQP4, EAATs, GABA, ND, PD, SNpc, STN |
| 82 |
2020 |
Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson's Disease and Diabetes. |
CCCP, HG, PD, ROS, TXNIP |
| 83 |
2020 |
Vascular endothelial growth factor-loaded poly-lactic-co-glycolic acid nanoparticles with controlled release protect the dopaminergic neurons in Parkinson's rats. |
NS, VEGF |
| 84 |
2020 |
Zonisamide promotes survival of human-induced pluripotent stem cell-derived dopaminergic neurons in the striatum of female rats. |
iPS, SLITRK6, ZNS |
| 85 |
2019 |
A Neuron-Glial Trans-Signaling Cascade Mediates LRRK2-Induced Neurodegeneration. |
BMP, Gbb, LRRK2, pMad |
| 86 |
2019 |
A test of dopamine hyper- and hyposensitivity in alcohol use. |
FRN |
| 87 |
2019 |
AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease. |
alpha-syn-WT, GFP, PD, SNpc |
| 88 |
2019 |
Activation of Peroxisome Proliferator-Activated Receptor-alpha Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons. |
Nurr1, PD, PPAR |
| 89 |
2019 |
Acute Tramadol-Induced Cellular Tolerance and Dependence of Ventral Tegmental Area Dopaminergic Neurons: An In Vivo Electrophysiological Study. |
VTA |
| 90 |
2019 |
Age-Associated Dopaminergic Neuron Loss and Midbrain Glia Cell Phenotypic Polarization. |
Arg1, BDNF, GDNF, IL-1beta, Lcn2, TNF-alpha |
| 91 |
2019 |
Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. |
alpha-Syn, ClpP, PD, SOD2 |
| 92 |
2019 |
Alterations and adaptation of ventral tegmental area dopaminergic neurons in animal models of depression. |
VTA |
| 93 |
2019 |
Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism. |
DA1, DMV, PD |
| 94 |
2019 |
AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression. |
AMPK, pAMPK, PD, SNpc |
| 95 |
2019 |
Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota. |
AQ, BU, BW, CT, EA, ET, PD |
| 96 |
2019 |
Anticancer Drugs for Parkinson's Disease: Is It a Ray of Hope or Only Hype? |
PD |
| 97 |
2019 |
Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity. |
DPSCs, GFAP, NO |
| 98 |
2019 |
Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus. |
AREs, hPSCs, PD, PKC, SN |
| 99 |
2019 |
Biochanin A protects against angiotensin II-induced damage of dopaminergic neurons in rats associated with the increased endophilin A2 expression. |
Ang II, AT1R, EPA2, GPCR |
| 100 |
2019 |
Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease. |
GAP43, MPTP, PD, TH, VEGF |
|
A Search Service for Abbreviation / Long Form
